
Shanghai branch of the Chinese subsidiary of Fortrea, the contract research organisation spun out of Labcorp in 2023 from the phase I to IV clinical trial and market access businesses of Covance and Chiltern. The Beijing parent company was established on 20 January 2005 with 6.8 million US dollars of registered capital and is based in the Chaoyang district of Beijing, and the business took the Chinese brand name Fuqirui when Fortrea launched in China in October 2023. Provides pharmaceutical research and development, laboratory testing, clinical development consulting, technical services and data processing for drug developers and manufacturers.
View Company Profile
Leave your rating